Human stem cell culture media are ingredients that require a slightly different approach to safety management than general ...
As biopharmaceutical development advances toward more complex biologics, vaccines, viral vectors, and cell and gene therapies, the demand for reliable analytical tools continues to grow. HYQURE ...
AI has changed the pace of biological discovery. The next test for industrial biotechnology is whether manufacturing can keep ...
Cell and gene therapy manufacturing relies on complex cell processing, viral vector production, quality control, and GMP-compliant workflows to consistently produce safe and effective therapies at ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
SOUTH SAN FRANCISCO, Calif. & LONDON--(BUSINESS WIRE)--Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation ...
As cell and gene therapies (CGTs) move closer to mainstream clinical use, manufacturers are under growing pressure to bridge the gap between scientific breakthroughs and commercial reality. To explore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results